Literature DB >> 2584716

Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum.

S M Puentes1, D M Dwyer, P A Bates, K A Joiner.   

Abstract

We have examined the nature and extent of C3 deposition on Leishmania donovani, strain 1S, clone 2D, promastigotes. Total molecules of C3 bound/parasite after 60 min was similar for parasites incubated in normal human serum, normal human serum adsorbed to remove natural antibody, or either serum source chelated with Mg-EGTA to limit activation to the alternative pathway. A comparison of parasites grown to early, mid, late-log or stationary phases revealed no difference in the extent and kinetics of C3 binding. C3 bound covalently to the parasite primarily through a hydroxylamine resistant (putatively amide) linkage. Of the bound C3, 75% was present as hemolytically inactive iC3b. Nearly 50% of the bound C3 was spontaneously released within 30 min at 37 degrees C. This spontaneous release was due to an unusual proteolytic cleavage event that released C3 from the C3 acceptor on the parasite surface. These results define and characterize the unusual features of C3 binding to L. donovani promastigotes during incubation in serum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2584716

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Differential surface deposition of complement proteins on logarithmic and stationary phase Leishmania chagasi promastigotes.

Authors:  Amanda E Ramer-Tait; Soi Meng Lei; Bryan H Bellaire; Jeffrey K Beetham
Journal:  J Parasitol       Date:  2012-06-04       Impact factor: 1.276

Review 2.  Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.

Authors:  R D Horstmann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  In silico sequence analysis, homology modeling and function annotation of leishmanolysin from Leishmania donovani.

Authors:  Somnath Waghmare; Abhishek Buxi; Yogesh Nandurkar; Anil Shelke; Ramrao Chavan
Journal:  J Parasit Dis       Date:  2015-02-28

4.  Synthesis of a Glycosylphosphatidylinositol Anchor Derived from Leishmania donovani That Can Be Functionalized by Cu-Catalyzed Azide-Alkyne Cycloadditions.

Authors:  Ning Ding; Xiuru Li; Zoeisha S Chinoy; Geert-Jan Boons
Journal:  Org Lett       Date:  2017-07-11       Impact factor: 6.005

Review 5.  Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

Authors:  Martin Olivier; David J Gregory; Geneviève Forget
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

6.  Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.

Authors:  M B Marques; D L Kasper; M K Pangburn; M R Wessels
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 7.  Innate immunity against Leishmania infections.

Authors:  Prajwal Gurung; Thirumala-Devi Kanneganti
Journal:  Cell Microbiol       Date:  2015-08-11       Impact factor: 3.715

8.  Attenuation of Leishmania infantum chagasi metacyclic promastigotes by sterol depletion.

Authors:  Chaoqun Yao; Upasna Gaur Dixit; Jason H Barker; Lynn M Teesch; Laurie Love-Homan; John E Donelson; Mary E Wilson
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

9.  Leishmanial protein kinases phosphorylate components of the complement system.

Authors:  T Hermoso; Z Fishelson; S I Becker; K Hirschberg; C L Jaffe
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Innate immune activation and subversion of Mammalian functions by leishmania lipophosphoglycan.

Authors:  Luis H Franco; Stephen M Beverley; Dario S Zamboni
Journal:  J Parasitol Res       Date:  2012-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.